Junlin Lu

1.1k total citations · 1 hit paper
33 papers, 760 citations indexed

About

Junlin Lu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Junlin Lu has authored 33 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Junlin Lu's work include Bladder and Urothelial Cancer Treatments (9 papers), Kidney Stones and Urolithiasis Treatments (8 papers) and Epigenetics and DNA Methylation (6 papers). Junlin Lu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Kidney Stones and Urolithiasis Treatments (8 papers) and Epigenetics and DNA Methylation (6 papers). Junlin Lu collaborates with scholars based in China and Hong Kong. Junlin Lu's co-authors include Shaogang Wang, Qi‐Dong Xia, Yang Xun, Cong Li, Jia Hu, Xu Chen, Tianxin Lin, Yuchao Lu, Ming Huang and Peng Zhou and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Junlin Lu

33 papers receiving 752 citations

Hit Papers

NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-... 2023 2026 2024 2025 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
    2023 128 citations Ruihui Xie, Liang Cheng et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junlin Lu China 14 325 203 164 129 111 33 760
Min Feng China 14 401 1.2× 91 0.4× 190 1.2× 66 0.5× 69 0.6× 28 822
Thomas U. Ahearn United States 18 292 0.9× 389 1.9× 354 2.2× 85 0.7× 255 2.3× 43 1.1k
Fa Sun China 14 267 0.8× 205 1.0× 73 0.4× 76 0.6× 32 0.3× 49 610
Hsiang‐Lin Lee Taiwan 17 292 0.9× 229 1.1× 149 0.9× 211 1.6× 144 1.3× 55 816
Yu-Feng Yan China 12 277 0.9× 151 0.7× 125 0.8× 157 1.2× 110 1.0× 24 731
Qiuhai Qian China 12 156 0.5× 185 0.9× 94 0.6× 94 0.7× 29 0.3× 15 524
Ewa Aleksandrowicz Poland 16 249 0.8× 93 0.5× 112 0.7× 102 0.8× 115 1.0× 27 713
Dimitrios Giakoustidis Greece 19 177 0.5× 111 0.5× 52 0.3× 282 2.2× 147 1.3× 67 799

Countries citing papers authored by Junlin Lu

Since Specialization
Citations

This map shows the geographic impact of Junlin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlin Lu more than expected).

Fields of papers citing papers by Junlin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junlin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlin Lu. The network helps show where Junlin Lu may publish in the future.

Co-authorship network of co-authors of Junlin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Junlin Lu. A scholar is included among the top collaborators of Junlin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junlin Lu. Junlin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Junlin, Hong Li, Tingting Li, et al.. (2025). Resveratrol Induces Oxidative Stress and Downregulates GPX4 and xCT to Activate the Ferroptosis Pathway for Anti-Bladder Cancer Organoids. Journal of Cancer. 16(8). 2613–2625. 2 indexed citations
2.
Zhan, Hengji, Bailin Pan, Junlin Lu, et al.. (2025). Reprogramming the tumor microenvironment with c-MYC-based gene circuit platform to enhance specific cancer immunotherapy. Nature Communications. 16(1). 7983–7983. 1 indexed citations
3.
4.
Liu, Chu, et al.. (2025). Advancements in genetic circuits as part of intelligent biotherapy for the treatment of bladder cancer: A review. PubMed. 12(1). e21200032–e21200032. 2 indexed citations
5.
Xia, Qi‐Dong, Jian‐Xuan Sun, Zhipeng Yao, et al.. (2024). The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG. npj Precision Oncology. 8(1). 216–216. 2 indexed citations
6.
Liu, Guangyao, Kanghua Xiao, Hong Li, et al.. (2024). Efficacy and Safety of Resveratrol in the Treatment of Bladder Cancer Derived Organoids. Advanced Therapeutics. 7(6). 1 indexed citations
7.
Wu, Yulun, Wei Liu, Wei Zhan, et al.. (2024). Sodium citrate targeting Ca2+/CAMKK2 pathway exhibits anti-tumor activity through inducing apoptosis and ferroptosis in ovarian cancer. Journal of Advanced Research. 65. 89–104. 22 indexed citations
8.
Xie, Ruihui, Liang Cheng, Ming Huang, et al.. (2023). NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer. Cancer Research. 83(10). 1666–1683. 128 indexed citations breakdown →
9.
10.
Xiao, Kanghua, Shengmeng Peng, Junlin Lu, et al.. (2023). UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer. Cell Death and Disease. 14(7). 408–408. 27 indexed citations
11.
Xu, Jin‐Zhou, Jian‐Xuan Sun, Wenjie Wang, et al.. (2023). Interconnections between urolithiasis and oral health: a cross-sectional and bidirectional Mendelian randomization study. Frontiers in Medicine. 10. 1174502–1174502. 1 indexed citations
12.
Xu, Jin‐Zhou, Qi‐Dong Xia, Jian‐Xuan Sun, et al.. (2023). Establishment of a novel indicator of pyroptosis regulated gene transcription level and its application in pan-cancer. Scientific Reports. 13(1). 17911–17911. 5 indexed citations
13.
Xia, Qi‐Dong, Yuan Zhang, Lisha Li, et al.. (2022). Identification of a Twelve Epithelial-Mesenchymal Transition-Related lncRNA Prognostic Signature in Kidney Clear Cell Carcinoma. Disease Markers. 2022. 1–18. 6 indexed citations
14.
Chen, Mingzhen, et al.. (2022). Ureteral calculi lithotripsy for single ureteral calculi: can DNN-assisted model help preoperatively predict risk factors for sepsis?. European Radiology. 32(12). 8540–8549. 14 indexed citations
15.
16.
Xu, Jin‐Zhou, Junlin Lu, Hu Liu, et al.. (2022). Sex Disparities in the Association of Serum Uric Acid With Kidney Stone: A Cross-Sectional Study in China. Frontiers in Medicine. 9. 774351–774351. 3 indexed citations
17.
Xia, Qi‐Dong, Yufeng Wang, Chen‐Qian Liu, et al.. (2021). Percutaneous Nephrolithotomy Can Reduce the Incidence of Sepsis Compared with Flexible Ureteroscopy in Treating Solitary Proximal Ureteral Stone Patients with Positive Urine Culture. BioMed Research International. 2021(1). 9927498–9927498. 5 indexed citations
18.
Lu, Junlin, Qi‐Dong Xia, Chen‐Qian Liu, et al.. (2021). Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guérin for Ta and T1 bladder cancer: a systematic review and meta-analysis. Translational Cancer Research. 10(6). 2849–2858. 5 indexed citations
19.
Xia, Qi‐Dong, Yang Xun, Junlin Lu, et al.. (2020). Development and Validation of a Nine-Redox-Related Long Noncoding RNA Signature in Renal Clear Cell Carcinoma. Oxidative Medicine and Cellular Longevity. 2020. 1–30. 49 indexed citations
20.
Lu, Junlin, Yang Xun, Xiao Yu, et al.. (2020). Albumin-globulin ratio: a novel predictor of sepsis after flexible ureteroscopy in patients with solitary proximal ureteral stones. Translational Andrology and Urology. 9(5). 1980–1989. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min Feng Breakdown of academic impact, for papers by Thomas U. Ahearn Breakdown of academic impact, for papers by Fa Sun Breakdown of academic impact, for papers by Hsiang‐Lin Lee Breakdown of academic impact, for papers by Yu-Feng Yan Breakdown of academic impact, for papers by Qiuhai Qian Breakdown of academic impact, for papers by Ewa Aleksandrowicz Breakdown of academic impact, for papers by Dimitrios Giakoustidis
Rankless by CCL
2026